The Ras protooncogenes play a fundamental role in the control of cell growth and differentiation. The importance of this control is highlighted by the frequency of association of mutationally activated Ras with human tumors. The long-term goal of this research project is to contribute to our understanding of the mechanisms by which Ras modulates cell proliferation. Our focus is on elucidating the nature of the dominant Ras effector pathways that mediate oncogenic Ras-induced growth and morphological transformation. A better understanding of these pathways is an important step in the search for therapeutic strategies to control onset and progression of cancer.
Our specific aims are: 1) to characterize a novel Ras effector pathway that contributes to regulation of cyclin D1 and NFkappaB via activation of Ral GTPases, 2) to assess the contribution of newly identified Ras-interacting proteins to Ras-mediated ell regulation, and 3) to explore the physical organization of Ras effector pathways as a means of regulating the specificity of signal transduction.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA071443-07
Application #
6513013
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Blair, Donald G
Project Start
1996-08-15
Project End
2005-05-31
Budget Start
2002-06-01
Budget End
2003-05-31
Support Year
7
Fiscal Year
2002
Total Cost
$273,000
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Cooper, Jonathan M; Ou, Yi-Hung; McMillan, Elizabeth A et al. (2017) TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer. Cancer Res 77:5077-5094
Wang, Chensu; Niederstrasser, Hanspeter; Douglas, Peter M et al. (2017) Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespan. Nat Commun 8:2270
Eskiocak, Banu; McMillan, Elizabeth A; Mendiratta, Saurabh et al. (2017) Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma. Cancer Discov 7:832-851
Wang, Chensu; Zhao, Tian; Li, Yang et al. (2017) Investigation of endosome and lysosome biology by ultra pH-sensitive nanoprobes. Adv Drug Deliv Rev 113:87-96
Thomas, Jemima C; Cooper, Jonathan M; Clayton, Natasha S et al. (2016) Inhibition of Ral GTPases Using a Stapled Peptide Approach. J Biol Chem 291:18310-25
Shields, Benjamin B; Pecot, Chad V; Gao, Hua et al. (2015) A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpression. Mol Syst Biol 11:842
Fisher, Kurt W; Das, Binita; Kim, Hyun Seok et al. (2015) AMPK Promotes Aberrant PGC1? Expression To Support Human Colon Tumor Cell Survival. Mol Cell Biol 35:3866-79
Pineda, Carlos T; Ramanathan, Saumya; Fon Tacer, Klementina et al. (2015) Degradation of AMPK by a cancer-specific ubiquitin ligase. Cell 160:715-728
Borkowski, Robert; Du, Liqin; Zhao, Zhenze et al. (2015) Genetic mutation of p53 and suppression of the miR-17?92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling. Cancer Res 75:666-75
Potts, Malia B; McMillan, Elizabeth A; Rosales, Tracy I et al. (2015) Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin B. Nat Chem Biol 11:401-8

Showing the most recent 10 out of 63 publications